학술논문
347 KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—data after minimum of 22 months of follow-up
Document Type
article
Author
Urban Emmenegger; Howard Gurney; Emanuela Romano; Neal Shore; Margitta Retz; Christian Poehlein; Charles Schloss; Leonard Appleman; Gwenaelle Gravis; Loïc Mourey; Josep Piulats; Evan Yu; Johann De Bono; William Berry; Peter Fong; Cristiano Ferrario; Tilman Todenhoefer; Henry Conter; Brigitte Laguerre; Xin Tong Li
Source
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Subject
Language
English
ISSN
2051-1426